Interferon-alpha and ribavirin treatment in a patient with hepatitis C virus-associated cutaneous periarteritis nodosa;Périartérite noueuse cutanée associée à une infection par le virus de l'hépatite C, régressive après une bithérapie antivirale

Annales de Dermatologie et de Venereologie

Volumn 133, Issue 8-9, 2006, Pages 679-682

  Naouri, M ^a   Bacq, Y ^a   Machet, M C ^a   Rogez, C ^b   Machet, L ^a  

^a UNIVERSITY HOSPITAL OF TOURS   (France)

^b Anatomocytopathologiste   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; ANTIMICROBIAL THERAPY; ARTERIOLE; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; FEMALE; GENOTYPE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LEG ULCER; POLYARTERITIS NODOSA; PURPURA; SKIN NECROSIS; SUBCUTANEOUS TISSUE; TREATMENT OUTCOME; VASCULITIS;

EID: 33748755723     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(06)70990-5     Document Type: Article

References (23)

1. Pawlotsky JM, Dhumeaux D, Bagot M. Hepatitis C virus in dermatology. A review. Arch Dermatol 1995;131:1185-93.
2. Dupin N, Chosidow O, Lunel F, Frances C. Quand demander une sérologie de l'hépatite C en dermatologie? Ann Dermatol Venereol 1994;121:574-8.
3. Sanchez-Perez J, De Castro M, Buezo GF, Fernandez-Herrera J, Borque MJ, Garcia-Diez A. Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection. Br J Dermatol 1996;134:715-9.
4. Schott P, Hartmann H, Ramadori G. Hepatitis C virus-associated mixed cryoglobulinemia. Clinical manifestations, histopathological changes, mechanisms of cryoprecipitation and options of treatment. Histol Histopathol 2001;16:1275-85.
5. Cacoub P, Maisonobe T, Thibault V, Gatel A, Servan J, Musset L, et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol 2001;28: 109-18.
6. Botero RC. Should patients with chronic hepatitis C infection be transplanted? Transplant Proc 2004;36:1449-54.
7. Cohen P, Guillevin L. Vascularites associées aux infections virales. Presse Med 2004;33:1371-84.
8. de Dios Garcia-Diaz J, Garcia-Sanchez M, Busteros JI, Arcos P. Polyarteritis nodosa after interferon treatment for chronic hepatitis C. J Clin Virol 2005;32:181-2.
9. Pateron D, Fain O, Sehonnou J, Trinchet JC, Beaugrand M. Severe necroziting vasculitis in a patient with hepatitis C virus infection treated by interferon. Clin Exp Rheumatol 1996;14:79-81.
10. Dohmen K, Miyamoto Y, Irie K, Takeshita T, Ishibashi H. Manifestation of cutaneous polyarteritis nodosa during interferon therapy for chronic hepatitis C associated with primary biliary cirrhosis. J Gastroenterol 2000;35:789-93.
11. Sepp NT, Umlauft F, Illersperger B, Grunewald K, Schuler G, Greil R, Vogel W. Necrotizing vasculitis associated with hepatitis C virus infection: successful treatment of vasculitis with interferon-alpha despite persistence of mixed cryoglobulinemia. Dermatology 1995;191:43-5.
12. Maillard H, Szczesniak S, Martin L, Garot D, Machet MC, Machet L, et al. Périartérite noueuse cutanée. Particularités diagnostiques et thérapeutiques de 9 cas. Ann Dermatol Venereol 1999;126:125-9.
13. Jorizzo JL. Classification of vasculitis. J Invest Dermatol 1993;100:106S-110S.
14. Soufir N, Descamps V, Crickx B, Thibault V, Cosnes A, Becherel PA, et al. Hepatitis C virus infection in cutaneous polyarteritis nodosa: a retrospective study of 16 cases. Arch Dermatol 1999;135:1001-2.
15. Zeuzem S, Diago M, Gane E, Reddy KR, Pockros P, Prati D, et al. Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels. Gastroenterology 2004;127:1724-32.
16. Daoud MS, Hutton KP, Gibson LE. Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases. Br J Dermatol 1997;136:706-13.
17. Misiani R, Bellavita P, Fenili D, Vicari O, Marchesi D, Sironi PL, et al. Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 1994;330:751-6.
18. Batisse D, Karmochkine M, Jacquot C, Kazatchkine MD, Weiss L. Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peg interferon alfa. Eur J Gastroenterol Hepatol 2004;16:701-3.
19. Boonyapisit K, Katirji B. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review. Muscle Nerve 2002;25:909-13.
20. Gordon AC, Edgar JD, Finch RG. Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemia. J Infect 1998;36:229-30.
21. Friedman G, Mehta S, Sherker AH. Fatal exacerbation of hepatitis C-related cryoglobulinemia with interferon-alpha therapy. Dig Dis Sci 1999;44:1364-5.
22. Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, et al. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2002;46:3317-26.
23. Hadziyannis SJ, Sette H Jr, Morgan TR, Balan V, Diago M, Marcellin P, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose. Ann Intern Med 2004;140:346-55.